Email Newsletters

NanoViricides

Shelton biotech raises $6M in direct offering, but warns of limited cash runway

Despite a recent capital raise, Shelton-based antiviral drug developer NanoViricides Inc. disclosed it does not have enough...
ADVERTISEMENT

Latest Stories

More Business News

Movers & Shakers

More Movers & Shakers | Submit an Announcement
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event
Close the CTA

Black Friday Sale! Get 40% off new subscriptions through Sunday, 11/30!